Over the past several years, there has been a steady rise in new biologic drugs coming onto the market for the treatment of chronic conditions such as multiple scler...

Industry 4.0 will be a game changer in how the patient will interact with all the partners who are involved in all aspects of the wellbeing of the end-user. Real-tim...

The intentions of the current study are to expedite the compliance requirements to support the regulatory approval for selected pharmaceuticals in the United States,...